Pharma Journalist -

Acorda Therapeutics announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA. Acorda is seeking marketing approval…
Read More...

FORMA Therapeutics and Arpeggio Biosciences announced a collaboration to utilize Arpeggio Biosciences’ proprietary technology to supplement FORMA’s analysis of the biological effects of…
Read More...

PharmaCyte Biotech, Inc. announced that it has filed a U.S. patent application with the United States Patent and Trademark Office (USPTO) to protect its therapy to treat cancerous…
Read More...

3P Biopharmaceuticals and Intervacc complete manufacturing agreement for new vaccine against equine strangles 3P Biopharmaceuticals and the Swedish company Intervacc have now…
Read More...

Astellas Pharma and Seattle Genetics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug…
Read More...

Shire plc and NanoMedSyn announced that the companies have entered into a preclinical research collaboration to evaluate a potential ERT using NanoMedSyn's proprietary synthetic…
Read More...

Teva Pharmaceutical Industries Ltd., announced the launch of a generic version of ALOXI®1 (palonosetron HCI) injection, 0.25 mg/5 mL, in the United States. Palonosetron hydrochloride…
Read More...

The Highly Potent Active Pharmaceutical Ingredients conference will be hosting 2 interactive half day post-conference workshops on the 23rd May, presented by HPAPI Project Services…
Read More...

Prothena Corporation announced a global collaboration with Celgene Corporation to develop new therapies for a broad range of neurodegenerative diseases. The multi-year research and…
Read More...

Regeneron Pharmaceuticals and Alnylam Pharmaceuticals announced a collaboration to identify RNAi therapeutics for the chronic liver disease nonalcoholic steatohepatitis (NASH) and…
Read More...